Advertisement

Molekulare Grundlagen der Interaktion zwischen Dopamin-(D1-/D2-)Rezeptoren

  • H. B. Niznik
  • R. K. Sunahara
  • Z. B. Pristupa
  • K. R. Jarvie
Conference paper

Zusammenfassung

Zahlreiche objektive und subjektive psychomotorische Symptome werden von der Aktivität dopaminerger Neurone und von Pharmaka beeinflußt, die selektiv mit den neuronalen Dopaminrezeptoren in Wechselwirkung treten (Davis et al. 1991; Goldstein u. Deutsch 1992). Zu den Symptomen gehören der Rigor bei Parkinson-Krankheit, Halluzinationen bei Schizophrenie und Alzheimer-Krankheit sowie Dyskinesien bei Chorea Huntington und spontane orale Dyskinesien im Alter (Seeman 1987; Seeman u. Niznik 1990). Die Dopaminrezeptoren wurden anhand biochemischer, pharmakologischer und physiologischer Kriterien in 2 Klassen eingeteilt, die mit D1 und D2 bezeichnet wurden (Kebabian u. Caine 1979; Seeman 1980; Niznik 1987; Niznik u. Jarvie 1989; Kebabian 1993; Hall 1994). Die Dopaminrezeptoren gehören zu einer großen Genfamilie von Hormon-/ Neurotransmitterrezeptoren, die ihre biologischen Wirkungen über bestimmte Signaltransduktionsmechanismen entfalten, an denen die Bindung von Guaninnukleotiden bzw. G-Proteine beteiligt sind (s. Kaziro et al. 1991; Simon et al. 1991; Hille 1992; Clapham u. Neer 1993). D2-Dopaminrezeptoren hemmen die Aktivität der Adenylatzyklase und scheinen die zahlreichen anderen Effektorsysteme miteinander zu koppeln (Dal Toso et al. 1989; Neve et al. 1989; Albert et al. 1990; Senogles et al. 1990; Vallar et al. 1990; Kanterman et al. 1991; Elsholtz et al. 1991; Castellano et al. 1993; Lledo et al. 1994), indem sie spezifische Subtypen von G-Proteinen aktivieren (Lledo et al. 1992; Missalle et al. 1991; Burris et al. 1992).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Agnati LF, Fuxe K, Benfenati F, Euler G von, Fredholm B (1993) Intramembrane receptor-receptor interactions: Integration of signal transduction pathways in the nervous system. Neurochem Int 22: 213–222PubMedCrossRefGoogle Scholar
  2. Albert PR, Neve KA, Bunzow JR, Civelli O (1990) Coupling of a cloned rat dopamine D2 receptor to inhibition of adenylate cyclase and prolactin secretion. J Biol Chem 265: 2098–2104PubMedGoogle Scholar
  3. Andersen PH, Gingrich JA, Bates MD et al. (1990) Dopamine receptor subtypes: beyond the D1/D2 classification. TIPS. 11: 231–236PubMedGoogle Scholar
  4. Artalejo CR, Ariano MA, Perlman RL, Fox AP (1990) Activation of facilitation calcium channels in chromaffin cells by D1 dopamine receptors through a cAMP/protein kinase A-dependent mechanism. Nature 348: 239–242PubMedCrossRefGoogle Scholar
  5. Bertorello AM, Hopfield JF, Aperia A, Greengard P (1990) Inhibition by dopamine of Na+K ATPase activity through D1 and D2 dopamine receptor synergism. Nature 347: 386–388PubMedCrossRefGoogle Scholar
  6. Bockaert J (1991) G-proteins and G-protein coupled receptors: structure, function and interactions. Curr Opin Neurobiol 1: 32–42PubMedCrossRefGoogle Scholar
  7. Bunzow JR, Van Tol HHM, Grandy DK et al. (1988) Cloning and expression of a rat 2 dopamine receptor CDNA. Nature (Lond) 336: 783–787CrossRefGoogle Scholar
  8. Burris TP, Nguyen DN, Smith SG, Freeman ME (1992) The stimulatory and inhibitory effects of dopamine on prolactin secrection involve different G-proteins. Endocrinology 130: 926–932PubMedCrossRefGoogle Scholar
  9. Cameron DL, Williams JT (1993) Dopamine D1 receptors facilitate transmitter release. Nature (Lond) 366: 344–347CrossRefGoogle Scholar
  10. Castellano MA, Liu LX, Monsma FJ, Sibley DR, Kapatos G, Chiodo LA (1993) Transfected D2 short dopamine receptors inhibit voltage dependent potassium current in neuroblastoma x glioma hybrid [NG 108–15] cells. Mol Pharmacology 44: 649–656Google Scholar
  11. Catalano M, Nobile M, Novelli E, Nothen MM, Smeraldi E (1993) Distribution of a novel mutation in the 1st exon of the human dopamine D4 receptor gene in psychotic patients. Biol Psychiatry 34: 459–464PubMedCrossRefGoogle Scholar
  12. Cheng HC, Nishio H, Hatase O, Ralph S, Wang JH (1992) A synthetic peptide derived from p34 cdc2 is a specific and effiecient substrate of src-family related kinases. J Biol Chem 267: 9248–9256PubMedGoogle Scholar
  13. Cheung AH, Huang RRC, Graziano MP, Strader CD (1991) Specifc activation of Gs by synthetic peptides corresponding to an intracellular loop of the 3-adrenergic receptor. FEBS Letts 279: 277–280CrossRefGoogle Scholar
  14. Cheung AH, Huang RRC, Strader CD (1992) Inovolement of specific hydrophobic, but not hydrophilic, amino acids in the third intracellular loop of the J3-adrenergic receptor in the activation of Gs. Mol Pharmacology 41: 1061–1065Google Scholar
  15. Civelli O, Bunzow JR, Grandy DK, (1993) Molecular diversity of the dopamine receptors. Ann Rev Pharmacol Toxicol 32: 281–307CrossRefGoogle Scholar
  16. Civelli O, Bunzow JR, Grandy DK, Zhou QY, Van Tol, HHM (1991) Molecular biology of the dopamine receptors. Eur J Pharmacol (Mol Pharmacology) 207: 277–286Google Scholar
  17. Clapham DE, Neer EJ (1993) New roles for G-protein J y-dimers in transmembrane signalling. Nature 365: 403–406Google Scholar
  18. Clark D, White FJ (1987) D1 dopamine receptor — the search for a function. Synapse 1: 347–388PubMedCrossRefGoogle Scholar
  19. Cleghorn JM, Zipursky RB, List, SJ (1991) Structural and functional brain imaging in schizophrenia. J Psychiatr Neurosci 16: 53–74Google Scholar
  20. Cole AJ, Bhat RV, Patt C, Worley PF, Baraban JM (1992) D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J Neurochem 58: 1420–1426PubMedCrossRefGoogle Scholar
  21. Collins S, Caron MG, Lefkowitz RJ (1992) From ligand binding to gene expression: new insights into the regulation of G-protein coupled receptors. TIBS 17: 37–39PubMedGoogle Scholar
  22. Cotecchia S, Ostrowski J, Kjelsberg MA, Caron MG, Lefkowitz RJ (1992) Discrete amino acid sequences of the al adrenergic receptor determine selectivity of coupling to PI hydrolysis. J Biol Chem 267: 1633–1639PubMedGoogle Scholar
  23. Dalman HM, Neubig RB (1991) Two peptides from the a2A-adrenergic receptor alter receptor G protein coupling by distinct mechanisms. J Biol Chem 266: 11025–11029PubMedGoogle Scholar
  24. Dal Toso R, Sommer B, Ewert M et al. (1989) The dopamine D2 receptor: two molecular forins generated by alternative splicing. EMBO J 8 /13: 4025–4034Google Scholar
  25. Davidson M, Harvey PD, Bergman PL et al. (1990) Effects of the D1 agonist SKF-38393 combined with haloperidol in schizophrenic patients. Arch Gen Psychiatr 47: 190–191PubMedGoogle Scholar
  26. Davis KL, Kahn RS, Ko G, Davidson M (1991) Dopamine in schizophrenia. A review and reconceptualization. Am J Psychiatry 148: 1474–1486PubMedGoogle Scholar
  27. Deutsch PJ, Sun Y (1992) The 38 amino acid form of pituitary adenylate cyclase activating polypeptide stimulates dual signaling casades in PC I2 cells and promotes neurite outgrowth.1 Biol Chem 267: 5108–5113Google Scholar
  28. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ (1991) Model systems for the study of seven transmembrane segment receptors. Ann Rev Biochem 60: 653–688PubMedCrossRefGoogle Scholar
  29. Dowling JE (1991) Retinal neuromodulation. The role of dopamine. Visual Neurosci 7: 87–97CrossRefGoogle Scholar
  30. Dowling JE (1994) The neuromodulatory role of dopamine in the teleost retina In. Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 37–57Google Scholar
  31. Elsholtz HP, Lew AM, Albert PR, Sundmark VC (1991) Inhibitory control of prolactin and Pit 1 gene promotors by dopamine: Dual signaling pathways required for D2 receptor regulated expression of the prolactin gene. J Biol Chem 266: 22915–22925Google Scholar
  32. Falardeau P (1994) Functional distinctions of dopamine D2 long and D2 short receptors In: Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 323–342Google Scholar
  33. Federman AD, Conklin BR, Schrader KA, Reed RR, Bourne HR (1992) Hormonal stimulation of adenyl cyclase through Gi-protein ßy subunits. Nature 356: 159–161PubMedCrossRefGoogle Scholar
  34. Felder CC, Blecher M, Jose PA (1989) Dopamine DI mediated stimulation of phospholipase C activity in rat cortical membranes. J Biol Chem 264: 8739–8745PubMedGoogle Scholar
  35. Felder CC, Albrecht FE, Campbell T, Eisner GM, Jose PA (1993) CAMP independent G-protein linked inhibition of Na+/H+ exchange in renal brush border by DI dopamine agonists. Am J Physiol 264: F1032 - F1037PubMedGoogle Scholar
  36. Gerfen CR, McGinty JF, Young WS (1991) Dopamine differentially regulated dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11: 1016–1031PubMedGoogle Scholar
  37. Gerfen CR (1992a) The neostriatal mosaic: multiple levels of compartmental organization. TINS 15: 133–139PubMedGoogle Scholar
  38. Gerfen CR (1992b) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Ann Rev Neurosci 15: 285–320PubMedCrossRefGoogle Scholar
  39. Gingrich JA, Jarvie KR, Tiberl M, Fremeau RT, Caron MG (1992) The family of receptors for dopamine: Cloning, structures and properties. Biotechnol Update 7:105–118Google Scholar
  40. Gerfen CR (1992a) The neostriatal mosaic: multiple levels of compartmental organization. TINS 15: 133–139PubMedGoogle Scholar
  41. Goldstein M, Deutch AY (1992) Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEBJ 6: 2413–2421Google Scholar
  42. Gomez-Mancilla B, Bedard PJ (1991) Effect of DI and D2 agonists on dyskinesia produced by L-dopa in MPTP treated monkeys. J Pharmacol Exp Ther 259: 409–413PubMedGoogle Scholar
  43. Grandy K, Bunzow JR, Civelli O (1994) The dopamine D2 receptor In: Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 151–164Google Scholar
  44. Haga K, Haga T (1992) Activation by G-protein (3y subunits of agonist or light dependent phosphorylation of muscarinic acetylcholine receptors and rhodopsin. J Biol Chem 267: 2222–2227PubMedGoogle Scholar
  45. Hall H (1994) Dopamine receptors: Radioligands for pharmacological and biochemical characterization. In: Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 3–35Google Scholar
  46. Harrison MB, Wiley RG, Wooten CF (1990) Selective localization of striatal DI receptors to striatonigral neurons. Brain Res. 528: 317–322PubMedCrossRefGoogle Scholar
  47. Hemmings HC, Walaas Sl, Oiumet CC and Greengard P (1987) Dopaminergic regulation of protein phosphorylation in the striatum: DARP-32. Trends Neurosci. 10: 77–82CrossRefGoogle Scholar
  48. Hüle, B (1992) G protein-coupled Mechanisms and nervous signaling. Neuron, 9: 187–195CrossRefGoogle Scholar
  49. Jarvie KR, Pristupa ZB, Sunahara RK, Niznik HB (1994) Dopamine D1 and D5 receptors: Sequences within the 3rd cytoplasmic loop of D5 display higher affinity for adenylate cyclase than DI. Mol Pharmacology (in preparation)Google Scholar
  50. Jarvie KR, Tiberi M, Caron MG (1994) The dopamine D5 and Dib receptors In Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 133–150Google Scholar
  51. Jones P, Murray RM (1991) The genetics of schizophrenia is the genetics of neurodevelopment. Br J Psychiatry 158: 615–623PubMedCrossRefGoogle Scholar
  52. Kanterman RY, Mahan LC, Briley EM et al. (1991) Transfected D2 dopamine receptors mediate the potentiation of aracadonic acid release in CHO cells. Mol Pharmacology 39: 364–369Google Scholar
  53. Kaziro Y, Itoh H, Kozasa T, Nakafuka M, Satoh T (1991) Structure and function of signal transducing GTP binding proteins. Ann Rev Biochem 60: 349–400PubMedCrossRefGoogle Scholar
  54. Kebabian JW (1993) Brain dopamine receptors–20 years of progress. Neurochemical Res 18: 101–104CrossRefGoogle Scholar
  55. Kebabian JW, Caine DB (1979) Multiple receptors for dopamine. Nature (Lond) 277: 93–96CrossRefGoogle Scholar
  56. Kemp BE, Pearson RB (1990) Protein kinase sequence motifs. TIBS 12: 342–346Google Scholar
  57. Kleuss C, Scherubl H, Hescheler J, Schultz G, Wittig B (1992) Different 0-subunits determine G-protein interaction with transmembrane receptors. Nature 358: 424–426PubMedCrossRefGoogle Scholar
  58. Kobilka BK (1992) Adrenergic receptors as models for G-protein coupled receptors. Ann Rev Neurosci 15: 87–114PubMedCrossRefGoogle Scholar
  59. Lahoste GL, Yu J, Marshall JF (1993) Striatal fos expression as indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc Natl Acad Sci (USA) 90: 7451–7455CrossRefGoogle Scholar
  60. Lankford KL, Demello FG, Klein WL (1988) Di type dopamine receptors inhibit growth cone motility in cultured retinal neurons: evidence that neurotransmitters act as morpho-genic regulators in the developing nervous system. Proc Natl Acad Sci (USA) 85: 2839–2843CrossRefGoogle Scholar
  61. Lemmon MA, Flanagan JM, Treutlein HR, Zhang J, Engleman DM (1992) Sequence spe- cifcity in the dimerization of transmembrane a helices. Biochemistry 31: 12719–12725PubMedCrossRefGoogle Scholar
  62. LeMoine C, Normand E, Bloch B (1991) Phenotypical characterization of rat striatal neurons expressing the Di dopamine receptor gene. Proc Natl Acad Sci (USA) 88: 4205–4209CrossRefGoogle Scholar
  63. Lester J, Fink S, Aronin N, Difiglia M (1993) Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons. Brain Res 621: 106–110PubMedCrossRefGoogle Scholar
  64. Levey AI, Hersch SM, Rye D et al. (1993) Localization of Di and D2 dopamine receptors in brain with subtype specific anti-bodies. Proc Natl Acad Sci (USA) 90: 8861–8865CrossRefGoogle Scholar
  65. Lew AM, Elsholtz HP (1994) Dopaminergic signalling and regulation of pituitary hormone genes. In: Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 473–491Google Scholar
  66. Lewine RRJ (1992) Brain morphology in schizophrenia. Cuff Opin Psychiatry 5: 92–97CrossRefGoogle Scholar
  67. Licther JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK, Livak KJ. A hypervariable segment in the human dopamine D4 (DRD 4) gene. Hum Mol Genetics 2:767–773Google Scholar
  68. Liu YF, Civelli O, Grandy DK, Albert PR (1992) Differential sensitivity of the short and long human dopamine D2 receptor subtypes to PKC. J Neurochem 59: 2311–2315PubMedCrossRefGoogle Scholar
  69. Lledo PM, Hamburger V, Bockeart J, Vincent JD (1992) Differential G-protein mediated coupling of D2 dopamine receptors to K+ and Ca2+ currents in rat anterior pituitary cells. Neuron 8: 455–463PubMedCrossRefGoogle Scholar
  70. Lledo PM, Vernier PH, Kukstas LA, Vincent JD, Hamburger V, Bockaert J (1994) Coupling of dopamine receptors to ionic channels in excitable tissues In Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 59–88Google Scholar
  71. Lovenberg TW, Nichols DE, Nestler EJ, Roth RH, Mailman RB (1991) Guanine nucleotide binding proteins and the regualtion of CAMP synthesis in NS2OY neuroblastoma cells: role of D1 dopamine and muscarinic receptors. Brain Res 556: 101–107PubMedCrossRefGoogle Scholar
  72. Malek D, Munch G, Palm D (1993) Two sites in the third inner loop of the dopamine D2 receptor are involved in functional G-protein mediated coupling to adenylate cyclase. FEBS Letts 325: 215–219CrossRefGoogle Scholar
  73. Mahan LC, Burch RM, Monsma FJ, Sibley DR (1990) Expression of striatal D1 dopamine receptors coupled to inositolphosphate production and calcium mobilization in Xenopus oocytes. Proc Natl Acad Sci (USA) 87: 2196–2200CrossRefGoogle Scholar
  74. McHugh D, Coffin V (1991) The reversal of extrapyramidal side effects with SCH-39166, a dopamine D1 receptor antagonist. Eur J Pharmacol 202: 133–134PubMedCrossRefGoogle Scholar
  75. McMillian MK, He XP, Hong JS, Pennypacker KR (1992) Dopamine stimulates [3H]- phorbol 12,13-dibutyrate binding in cultured striatal cells. J Neurochem 58: 1308–1312PubMedCrossRefGoogle Scholar
  76. Missale C, Boroni F, Castelletti L et al. (1991) Lack of coupling of D2 receptors to adenylate cyclase in GH 3 cells exposed to epidermal growth factor: Possible role of a differential expression of Gi protein subtypes. J Biol Chem 266: 23392–23398PubMedGoogle Scholar
  77. Montmayer JP, Bonelli E (1991) Transcription mediated by a CAMP-responsive promotor element is reduced upon activation of dopamine D2 receptors. Proc Natl Acad Sci (USA) 88: 3135–3139CrossRefGoogle Scholar
  78. Morell R (1993) Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 30: 708PubMedCrossRefGoogle Scholar
  79. Mukai H, Munekata E, Higashijima T (1992) G protein antagonists. A novel hydrphobic peptide competes with receptor for G-protein binding. J. Biol Chem 267: 16237–16243PubMedGoogle Scholar
  80. Nagai Y, Uneo S, Saeki Y, Soga F, Yanagihara T (1993) Expression of a D3 receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lympocytes. Biochem Biophys Res Commun 194: 368–374PubMedCrossRefGoogle Scholar
  81. Neve KA, Henningsen RA, Bunzow JR, Civelli 0 (1989) Functional characterization of a rat dopamine D2 receptor CDNA expressed in a mammalian cell line. Mol Pharmacology 36: 446–451Google Scholar
  82. Niznik HB (1987) Dopamine receptors; molecular structure and function. Mol Cell Endocrinol 54: 1–22PubMedCrossRefGoogle Scholar
  83. Niznik HB, Jarvie KR (1989) Dopamine receptors. In: Williams M, Glennon RA, Timmermans PB (eds) Receptor pharmacology and function. Dekker, New York Basel, pp 717–768Google Scholar
  84. Niznik HB, ODowd BF, Sunahara RK et al. (1992) The dopamine D1 receptors. In: Braun MR (ed) Molecular biology of receptors that couple to G-proteins. Birkhäuser, Boston, pp 142–159Google Scholar
  85. Niznik HB, Van Tol HHM (1992) Dopamine receptor genes: New tools for molecular psychiatry. J Psychiatry Neurosci 17: 158–180PubMedGoogle Scholar
  86. Nothen MM, Cichon S, Propping P, Fimmers R, Schwab SG, Wildenauer DB (1993) Excess of homozygosity at the dopamine D3 receptor gene in schizophrenia not confirmed. J Med Genet 30: 708PubMedCrossRefGoogle Scholar
  87. Ohara K, Ulpian C, Seeman P, Sunahara K, Van Tol HHM, Nizrtik HB (1993) Schizophrenia: dopamine D1 receptor sequence is normal but has several DNA polymorphisms. Neuropsychopharmacol 8: 131–135Google Scholar
  88. Okamaoto T, Katada T, Murayama T, Ui M, Ogata E, Nishimoto I (1990) A simple structure encodes G-protein activation G function of the IGF-H mannose 6 phosphate receptor. Cell 62: 709–717CrossRefGoogle Scholar
  89. Okamaoto T, Murayama Y, Hayashi Y, Inagaki M, Ogata E, Nishimoto I (1991) Identification of a Gs activator region of the fl-adrenergic receptor that is autoregulated via PKA dependent phosphorylation. Cell 67: 723–730CrossRefGoogle Scholar
  90. Okamaoto T, Nishimoto I (1992) Detection of G-protein activator regions in the M4 subtype muscarinic cholinergic and a2 adrenergic receptors based upon characteristics in primary structure. J Biol Chem 267: 8342–8346Google Scholar
  91. Ostrowski J, Kjelsberg MA, Caron MG, Lefkowitz RJ (1992) Mutagenesis of the ß2 adrenergic receptor: How structure elucidates function. Ann Rev Pharmacol Toxicol 32: 167–183CrossRefGoogle Scholar
  92. Pagliusi S, Cholletdaemerius A, Losberger C, Mills A, Kawashima E (1993) Characterization of a novel exon within the D3 receptor gene giving rise to an mRNA isoform expressed in rat brain. Biochem Biophys Res Commun 194: 465–471PubMedCrossRefGoogle Scholar
  93. Pilowsky LS, Kerwin RW, Murray RM (1993) Schizophrenia — a neurodevelopmental perspective. Neuropsychopharmacol 9: 83–91Google Scholar
  94. Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, Schwartz JC (1991) Dopamine activation of the arachidonic acid cascade as a basis for Dl/D2 receptor synergism. Nature 353: 164–167PubMedCrossRefGoogle Scholar
  95. Pitcher JA, Inglese J, Higgins JB et al. (1992) Role of ß/y subunits of G proteins in targeting the bARK to membrane bound receptors. Science 257: 1264–1267PubMedCrossRefGoogle Scholar
  96. Power RF, Mani SK, Codina J, Conneely OM, OMalley BW (1991) Dopaminergic and li- gand independent activation of steroid hormone receptors. Science 254: 1636–1639PubMedCrossRefGoogle Scholar
  97. Rappaport MS, Sealfon SC, Prikhozhan A, Huntley GW, Morrison JH (1993) Heterogeneous distribution of D1, D2 and D5 receptor m-RNAs in monkey striatum. Brain Res 616: 242–250PubMedCrossRefGoogle Scholar
  98. Robertson GS, Robertson HA (1994) Dopamine receptor regulation of immediate early genes in the basal ganglia. In: Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 419–436Google Scholar
  99. Robertson HA (1992) Dopamine receptor interactions: some implications for the treatment of Parkinson’s disease. TINS 15: 201–206PubMedGoogle Scholar
  100. Robertson HA, Paul ML. Moratalla R, Graybiel AM (1991) Expression of the immediate early response gene c-fos in basal ganglia: Induction by dopaminergic drugs. Can J Neurol Sci 18:380–383PubMedGoogle Scholar
  101. Robertson HA, Paul ML, Robertson GS (1990) Interactions between D1 and D2 dopamine receptors: The immediate early response gene c-fos in long term changes in the striatum. In: Bernardi G (ed) The basal banglia III. Plenum Press, New York, pp 417–423Google Scholar
  102. Rodrigues PDS, Dowling JE (1990) Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C. Proc Natl Acad Sci (USA) 87: 9693–9697CrossRefGoogle Scholar
  103. Rosengarten H, Schweitzer JW, Freidhoff AJ (1993) A subpopulation of dopamine D1 receptors mediate repetitive jaw movements in rats. Pharmacol Biochem Behav 45: 921–924PubMedCrossRefGoogle Scholar
  104. Ruiz J, Gabilondo AM, Meana JJ, Garciasevilla JA (1992) Increased [3H]-raclopride binding sites in postmortem brains from schizophrenic violent suicide victims. Psycho-pharmacology 109: 410–414Google Scholar
  105. Sarkar G, Kapelner S, Grandy DK et al. (1991) Direst sequencing of the dopamine D2 receptor in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 11: 8–14PubMedCrossRefGoogle Scholar
  106. Schimmer B (1979) Adrenocortical Y1 cells. Methods Enzymol 52: 570–574CrossRefGoogle Scholar
  107. Schmauss C, Haroutunian V, Davis KL, Davidson M (1993) Selective loss of dopamine D3 type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proc Natl Acad Sci (USA) 90: 8942–8946CrossRefGoogle Scholar
  108. Schmidt CJ, Thomas TC, Levine MA, Neer EJ (1992) Specificity of G-protein ß and y subunit interaction. J Biol Chem 267: 13807–13810PubMedGoogle Scholar
  109. Schwartz JC, Levesque D, Martres MP, Sokoloff P (1993) Dopamine D3 receptor — basic and clinical aspects. Clin Neuropharmacol 16: 295–314PubMedCrossRefGoogle Scholar
  110. Seeman P(1980) Dopamine receptors. Pharmacol Rev 32:229–313PubMedGoogle Scholar
  111. Seeman P (1987) Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1: 133–152PubMedCrossRefGoogle Scholar
  112. Seeman P (1992) Dopamine receptor sequences: Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychpharmacology 7: 261–284Google Scholar
  113. Seeman P, Guan HC, Civelli O, Van Tol HHM, Sunahara RK, Niznik HB (1992) The cloned dopamine D2 receptors reveals different densities for dopamine antagonist ligands: Implications for human brain positron emission tomography. Eur J Pharmacol 227: 139–146PubMedCrossRefGoogle Scholar
  114. Seeman P, Guan HC, and Van Tol HHM (1993) Dopamine D4 receptors elevated in schizophrenia. Nature 365: 441–445PubMedCrossRefGoogle Scholar
  115. Seeman P, Niznik HB (1988) Dopamine D1 receptor pharmacology. ISI Atlas Sci Pharmacol 2: 161–170Google Scholar
  116. Seeman P, Niznik HB (1990) Dopamine receptors and transporters in Parkinson’s disease and schizophrenia. FASEB J 4: 2737–2744PubMedGoogle Scholar
  117. Seeman P, Niznik H, Guan HC (1990) Elevation of D2 dopamine receptors in schizophre- nia are underestimated by radioactive raclopride. Arch Gen Psychiatry 47: 1170–1172PubMedGoogle Scholar
  118. Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C (1989) Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc Natl Acad Sci (USA) 86: 10156–10160CrossRefGoogle Scholar
  119. Seeman P, Ohara K, Ulpian C et al. (1993a) Schizophrenia: Normal sequence in the dopamine D2 receptor region that couples to G-proteins. DNA polymorphisms in D2. Neuropsychopharmacology 8: 137–142PubMedGoogle Scholar
  120. Seeman P, Sunahara RK, Niznik HB (1994) Receptor-receptor link in membranes revealed by ligand competition: Example for dopamine D1 and D2 receptors. Synapse (in press)Google Scholar
  121. Senogles SE, Spiegel AM, Padress W, Iyengar R, Caron MG (1990) Specificity of receptor-G protein interactions: Discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted system. J Biol Chem 265: 4507–4514PubMedGoogle Scholar
  122. Sibley DR and Monsma FJ (1992) Molecular biology of dopamine receptors. TEPS 13: 61–69Google Scholar
  123. Sidhu A, Sullivan M, Kohout T, Balen P, Fishman P (1991) DI dopamine receptors can interact with both stimulatory and inhibitory gunaine nucleotide binding proteins. J Neurochem 57: 1445–1451PubMedCrossRefGoogle Scholar
  124. Simon MI, Strathmann MP, Narasimhan G (1991) Diversity of G-proteins in signal transduction. Science 252: 802–808PubMedCrossRefGoogle Scholar
  125. Sokoloff P, Martre MP, Giros B et al. (1994) The dopamine D3 receptor. In: Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 165–188Google Scholar
  126. Srivastava LK and Mishra RK (1994) Dopamine receptor gene expression: Effects of neuroleptics, denervation and development. In: Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 437–457Google Scholar
  127. Sunahara RK, Niznik HB, Weiner DM et al. (1990) Human dopamine DI receptor encoded by an intronless gene on chromosome 5. Nature 347: 80–83PubMedCrossRefGoogle Scholar
  128. Sunahara RK, Guan HC, O’Dowd BF et al. (1991) Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350: 614–619PubMedCrossRefGoogle Scholar
  129. Sunahara RK, Seeman P, Van Tol HHM, Niznik HB (1993) Dopamine receptors and antipsycotic drug response. Br J Psychiatr 164 [Suppl 22]: 31–38Google Scholar
  130. Sunahara RK, Lawrence J, Guan Hj, Seeman P, Niznik HB (1994) Subtype specific dopamine D1/D2 receptor interactions are regulated by 13/y G-protein subunits. Mol Pharmacol (in preparation)Google Scholar
  131. Surmeier DJ, Reiner A, Levine MS, Ariano MA (1993) Are neostriatal fopamine receptors co-localized. Trends Neurosci 16: 299–305PubMedCrossRefGoogle Scholar
  132. Tang Wj, Gilman AG (1991) Type specific regulation of adenylate cyclase by G-protein ßy subunits. Science 254: 1500–1503PubMedCrossRefGoogle Scholar
  133. Turgeon JL, Warring (1992) Functional cross-talk between receptors for peptide and steriod hormones. Trends Endocrinol Metabol 3: 360–365Google Scholar
  134. Undie AS, Friedman E (1990) Stimulation of a dopamine DI receptor enhances inositol phosphate formation in rat brain. J Pharmacol Exp Ther 253: 987–992PubMedGoogle Scholar
  135. Undie AS, Friedman E (1992) Characteristics of dopamine stimulated PI metabolism in rat brain. Soc Neurosci (Abstr 18, p 275 )Google Scholar
  136. Vallar L, Muca C, Magni M, Albert P, Bunzow JR, Meldolesi J, Civelli O (1990) Differential coupling of dopaminergic D2 receptors expressed in different cell types: stimulation of phosphatidylinositol 4,5 biphosphate in LTk-fibroblasts, hyperpolarization and cytosolic free Ca2+ concentration decrease in GH4C1 cells. J Biol Chem 265: 10320–10326PubMedGoogle Scholar
  137. Van Tol HHM (1994) The dopamine D4 receptor. In Niznik HB (ed) Dopamine receptors and transporters: Pharmacology, structure and function. Dekker, New York, pp 189–204Google Scholar
  138. Van Tol HHM, Bunzow JR, Guan HC et al. (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610–614PubMedCrossRefGoogle Scholar
  139. Van Tol HHM, Wu CM, Guan et al. (1992) Multiple dopamine D4 receptor variants in the human population. Nature 358: 149–152PubMedCrossRefGoogle Scholar
  140. Waddington JL (1989) Functional interactions between D1 and D2 dopamine receptor systems. J Psychopharmacol 3: 54–63CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • H. B. Niznik
  • R. K. Sunahara
  • Z. B. Pristupa
  • K. R. Jarvie

There are no affiliations available

Personalised recommendations